Member Services
memberservices@aan.com
(800) 879-1960
(612) 928-6000
email to a friend |
print |
Post a comment
| Login to rate this article
The AAN seeks comments by Sunday, February 24, 2013, to be used in developing new guideline recommendations on pharmacologic and behavioral treatment of autism spectrum disorder.
Disclaimer: The opinions expressed in this posting are those of the author only and do not represent the views of the American Academy of Neurology or any of its affiliated subsidiaries.
Please login to view and submit comments.
memberservices@aan.com
(800) 879-1960
(612) 928-6000